| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 204.10B | 200.06B | 194.36B | 207.94B | 162.55B | 143.49B |
| Gross Profit | 75.22B | 63.29B | 62.48B | 58.30B | 54.81B | 56.78B |
| EBITDA | 31.90B | 29.85B | 28.63B | 26.62B | 24.65B | 24.74B |
| Net Income | 13.27B | 11.55B | 10.82B | 10.57B | 9.97B | 9.37B |
Balance Sheet | ||||||
| Total Assets | 153.65B | 156.07B | 159.56B | 154.93B | 153.90B | 140.38B |
| Cash, Cash Equivalents and Short-Term Investments | 17.06B | 19.81B | 18.99B | 13.05B | 17.02B | 12.45B |
| Total Debt | 50.67B | 46.94B | 47.19B | 40.58B | 45.94B | 41.51B |
| Total Liabilities | 90.78B | 88.61B | 86.83B | 80.63B | 82.00B | 71.03B |
| Stockholders Equity | 62.39B | 67.45B | 72.72B | 74.30B | 71.89B | 69.34B |
Cash Flow | ||||||
| Free Cash Flow | 19.69B | 22.15B | 17.36B | 15.10B | 13.32B | 3.81B |
| Operating Cash Flow | 26.08B | 27.92B | 23.44B | 19.59B | 20.69B | 16.07B |
| Investing Cash Flow | -7.42B | -8.81B | -9.19B | -7.58B | -8.79B | -14.51B |
| Financing Cash Flow | -15.81B | -18.39B | -8.71B | -16.07B | -7.41B | -5.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥90.01B | 8.94 | 9.07% | 3.61% | 9.39% | 77.24% | |
75 Outperform | ¥107.15B | 8.99 | 7.99% | 3.89% | 1.08% | 37.11% | |
73 Outperform | ¥459.75B | 28.19 | 6.03% | 1.81% | 7.08% | 43.50% | |
72 Outperform | ¥2.62T | 14.41 | 11.05% | 1.53% | 5.72% | 148.08% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
64 Neutral | ¥323.55B | 19.17 | 20.44% | 3.28% | 4.45% | 53.88% | |
63 Neutral | ¥2.44T | 11.58 | 10.44% | 1.98% | 1.99% | 95.71% |